Product Details:
Minimum Order Quantity | 6 Stripe |
Strength | 0.5 mg |
Everolimus is indicated for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer (advanced HR+ BC) in combination with exemestane, after failure of treatment with letrozole or anastrozole.